Stock Analysts’ Price Target Changes for December 15th (ALNY, BBIO, DRI, EAT, ETSY, MTD, PACB, PGR, SEAT, SO)

Stock Analysts’ price target changes for Monday, December 15th:

Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target cut by Leerink Partners from $370.00 to $351.00. They currently have a market perform rating on the stock.

BridgeBio Pharma (NASDAQ:BBIO) had its target price increased by Leerink Partners from $75.00 to $86.00. The firm currently has an outperform rating on the stock.

Darden Restaurants (NYSE:DRI) had its target price trimmed by Jefferies Financial Group Inc. from $210.00 to $200.00. Jefferies Financial Group Inc. currently has a hold rating on the stock.

Brinker International (NYSE:EAT) had its price target boosted by Jefferies Financial Group Inc. from $125.00 to $155.00. The firm currently has a hold rating on the stock.

Etsy (NASDAQ:ETSY) had its price target lowered by Citigroup Inc. from $73.00 to $60.00. The firm currently has a neutral rating on the stock.

Mettler-Toledo International (NYSE:MTD) had its target price lowered by Barclays PLC from $1,600.00 to $1,550.00. They currently have an overweight rating on the stock.

Pacific Biosciences of California (NASDAQ:PACB) had its price target increased by Barclays PLC from $1.50 to $2.00. They currently have an equal weight rating on the stock.

Progressive (NYSE:PGR) had its price target trimmed by Citigroup Inc. from $301.38 to $300.60. The firm currently has a buy rating on the stock.

Vivid Seats (NASDAQ:SEAT) had its price target lowered by Citigroup Inc. from $10.00 to $8.50. The firm currently has a neutral rating on the stock.

Southern (NYSE:SO) had its price target lowered by Jefferies Financial Group Inc. from $104.00 to $93.00. Jefferies Financial Group Inc. currently has a neutral rating on the stock.

Trex (NYSE:TREX) had its price target lowered by Citigroup Inc. from $52.00 to $39.00. They currently have a neutral rating on the stock.